Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
1196
-
Total 13F shares, excl. options
-
86.7M
-
Shares change
-
-2.28M
-
Total reported value, excl. options
-
$48.8B
-
Value change
-
-$1.23B
-
Put/Call ratio
-
0.66
-
Number of buys
-
620
-
Number of sells
-
-516
-
Price
-
$562.27
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2025
1,383 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2025.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 86.7M shares
of 105M outstanding shares and own 82.58% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9.05M shares), BlackRock, Inc. (8.84M shares), STATE STREET CORP (4.69M shares), Dodge & Cox (4.55M shares), JPMORGAN CHASE & CO (4.07M shares), GEODE CAPITAL MANAGEMENT, LLC (2.54M shares), FRANKLIN RESOURCES INC (2.45M shares), Capital World Investors (2M shares), LOOMIS SAYLES & CO L P (1.98M shares), and FMR LLC (1.94M shares).
This table shows the top 1196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.